Real life efficacy of ledipasvir/sofosbuvir in hepatitis C genotype 4–infected patients with advanced liver fibrosis and decompensated cirrhosis

Authors: Sanai, Faisal M., Altraif, Ibrahim H., Alswat, Khalid, AlZanbagi, Adnan, Babatin, Mohamed A., AlMousa, Abdallah, Almutairi, Nawaf H, Aljawad, Mohammed S., Alghamdi, Abdullah S., Aljumah, Abdulrahman A., Alalwan, Abduljaleel M., Al-Hamoudi, Waleed K., Assiri, Abdullah M., Dahlan, Yaser, Alsahafi, Ashwaq, Alothmani, Hammad S., AlSaleemi, Mohammed S., Mousa, Waleed A., Albenmousa, Ali, Awny, Abdelrahman, Albiladi, Haziz, Abdo, Ayman A., AlGhamdi, Hamdan

Source: In Journal of Infection June 2018 76(6):536-542

Treatment efficacy of ledipasvir/sofosbuvir for 8 weeks in non-cirrhotic chronic hepatitis C genotype 4 patients

Authors: Babatin, Mohammed, AlGhamdi, Abdullah, Assiri, Abdullah, AlBiladi, Haziz, AlOthmani, Hammad, Mogharbel, Mohammed, Mahallawi, Wedad, Asselah, Tarik, Sanai, Faisal

Source: Saudi journal of gastroenterology. 25(1):55-60

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100088737337.0x000001&indx=1&recIds=ETOCvdc_100088737337.0x000001

Efficacy and Safety of Simeprevir or Daclatasvir in Combination With Sofosbuvir for the Treatment of Hepatitis C Genotype 4 Infection

Authors: Babatin, Mohammed A., Alghamdi, Abdullah S., Albenmousa, Ali, Alaseeri, Abdulla, Aljarodi, Mahdi, Albiladi, Haziz, Alsahafi, Ashwaq, Almugharbal, Mohammed, Alothmani, Hammad S., Sanai, Faisal M., Bzeizi, Khalid I.

Source: Journal of clinical gastroenterology. 52(5):452-457

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100057526835.0x000001&indx=1&recIds=ETOCvdc_100057526835.0x000001

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Efficacy and Safety of Simeprevir or Daclatasvir in Combination With Sofosbuvir for the Treatment of Hepatitis C Genotype 4 Infection.

Authors: Babatin, Mohammed A, Alghamdi, Abdullah S, Albenmousa, Ali, Alaseeri, Abdulla, Aljarodi, Mahdi, Albiladi, Haziz, Alsahafi, Ashwaq, Almugharbal, Mohammed, Alothmani, Hammad S, Sanai, Faisal M, Bzeizi, Khalid I

Source: Journal of Clinical Gastroenterology; Aug2017, Vol. 51 Issue 7, pN.PAG-N.PAG, 1p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.